Evidence map›Paper›PMID 34405968›Full record

Observational studyCancer reports (Hoboken, N.J.)2022

Psychosocial perspectives among cancer patients during the coronavirus disease 2019 (COVID-19) crisis: An observational longitudinal study.

Ilit Turgeman, Tal Goshen-Lago, Ithai Waldhorn, Keren Karov, Leora Groisman, Anat Reiner Benaim, Ronit Almog, Michael Halberthal, Irit Ben-Aharon

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Cancer reports (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Patient-reported experiences of cancer care related to the COVID-19 pandemic in Switzerland.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  5. Article
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ilit TurgemanDivision of Oncology, Rambam Health Care Center, Haifa, Israel.ORCID 0000-0003-4123-1107
Tal Goshen-LagoDivision of Oncology, Rambam Health Care Center, Haifa, Israel.
Ithai WaldhornDivision of Oncology, Rambam Health Care Center, Haifa, Israel.
Keren KarovDivision of Oncology, Rambam Health Care Center, Haifa, Israel.
Leora GroismanDivision of Oncology, Rambam Health Care Center, Haifa, Israel.
Anat Reiner BenaimClinical Epidemiology Unit, Rambam Health Care Campus, Haifa, Israel.
Ronit AlmogTechnion Integrated Cancer Center (TICC), Faculty of Medicine, Haifa, Israel.
Michael HalberthalTechnion Integrated Cancer Center (TICC), Faculty of Medicine, Haifa, Israel.
Irit Ben-AharonDivision of Oncology, Rambam Health Care Center, Haifa, Israel.
Rambam Health Care Campus · ILTechnion – Israel Institute of Technology · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) crisis and consequent changes in medical practice have engendered feelings of distress in diverse populations, potentially adversely affecting the psychological well-being of cancer patients.

aimThe purpose of this observational longitudinal study was to evaluate psychosocial perspectives among patients with cancer on intravenous treatment during the COVID-19 pandemic. METHODS AND

resultsThe study recruited 164 cancer patients undergoing intravenous anti-neoplastic therapy in a tertiary cancer center. Psychosocial indices were assessed at two points in time, corresponding with the beginning of the first wave of COVID-19 pandemic in Israel (March 2020) and the time of easing of restrictions implemented to curtail spread of infection (May 2020). At Time 1 (T1), elevated COVID-19 distress levels (score 1 and 2 on 5-point scale) were observed in 44% of patients, and associated with pre-existing hypertension and lung disease in multivariate analyses but no demographic or cancer related factors. At Time 2 (T2), 10% had elevated anxiety and 24% depression as indicated by Hospital Anxiety and Depression Scale (HADS-A/D). COVID-19 distress at T1 was related to higher levels of HADS-A at T2 (Spearman 0.33 p < .01), but not HADS-D. Patients with breast cancer expressed greater COVID-19 distress compared with other cancer types (p < .01), while both HADS-A and HADS-D were highest for patients with GI cancer. Patient report of loneliness and decreased support from relatives were factors associated with HADS-A (p = .03 and p < .01, respectively), while HADS-D was not similarly related to the factors evaluated.

conclusionPatients with cancer undergoing intravenous treatment may be vulnerable to acute adverse psychological ramifications of COVID-19, specifically exhibiting high levels of anxiety. These appear unrelated to patient age or disease stage. Those with underlying comorbidities, breast cancer or reduced social support may be at higher risk.

Indexed as

Breast NeoplasmsCOVID-19DepressionFemaleHumansLongitudinal StudiesPandemicsSARS-CoV-2clinical observationsmedical oncologypsychosocial studiesquality of life

Identifiers

PMID34405968
PMCPMC8420321
OpenAlexW3194314934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.